IntraPace, Inc. announced today that it has received CE Mark for the LGL102, a new gastric stimulation/food sensing lead designed to work with the innovative abiliti system, an implantable weight loss management system.

Rosetta Genomics, Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces that results from a joint study by researchers at the Institutes of Oncology, Davidoff Center, Rabin Medical Center, Beilinson Hospital and Golda-Hasharon Hospital in Petach-Tikva, Israel show that in post-resection gastric cancer patients microRNAs may ...

Rosetta Genomics, Ltd., a leading developer and provider of microRNA-based molecular diagnostics, announces that results from a joint study by researchers at the Institutes of Oncology, Davidoff Center, Rabin Medical Center, Beilinson Hospital and Golda-Hasharon Hospital in Petach-Tikva, Israel show that in post-resection gastric cancer patients microRNAs may serve to ...

In the October 20th edition of the journal Cell Host and Microbe, Drs. Claudia Plottel and Martin J. Blaser of the Departments of Medicine and Microbiology at NYU Langone Medical Center, and the Department of Biology at New York University, present a model for understanding how cancer evolves in humans ...

Family members of patients who have undergone surgery for weight loss may also shed several pounds themselves, as well as eat healthier and exercise more, according to a new study by researchers at Stanford University School of Medicine. A year after the 35 patients in the study had Roux-en-Y gastric ...

Family members of patients who have undergone surgery for weight loss may also shed several pounds themselves, as well as eat healthier and exercise more, according to a new study by researchers at Stanford University School of Medicine.

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, announced today top-line results from study 303, a Phase 3 trial designed to track the long-term safety of PA32540 in patients who are at risk for developing aspirin-associated gastric ulcers.

The kidneys play an important role in the regulation of blood pressure by adjusting the production of urine after eating or drinking. This process begins already in the upper digestive tract, which could explain why gastric bypass surgery for obesity also markedly reduce blood pressure, reveals a thesis from the ...

The stomach bacterium Helicobacter pylori is one of the biggest risk factors for the development of gastric cancer, the third most common cause of cancer-related deaths in the world.

FRIDAY, Aug. 5 (HealthDay News) -- The most common type of weight loss surgery in the United States appears to help patients shed pounds by reducing their intake of fatty foods and helping them stick to a healthier diet, a new study indicates. In Roux-en-Y gastric bypass, the stomach ...

Stomach cancer is actually two distinct disease variations based on its genetic makeup, and each responds differently to chemotherapy, according to an international team of scientists led by researchers at Duke-National University of Singapore Graduate Medical School. The finding, published in the Aug. 1, 2011, edition of the journal Gastroenterology, ...

Roux-en-Y gastric bypass, the most common type of bariatric surgery in the United States, is currently considered the most effective therapy for morbid obesity. Patients who undergo this procedure, in which the stomach is reduced to a small pouch and connected to the middle of the small intestine, often lose ...